Iron Mountain Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$158.54M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $279.07B · View financials
Decision snapshot: IRM stock price vs IBM: inconclusive — current versus $12.99 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IBM's multiple
Implied fair value · at IRM's multiple
Needs IRM P/E.
Close Dec 31, 2025
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
IRON MOUNTAIN INC · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
INTERNATIONAL BUSINESS MACHINES CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe IRM can sustain faster growth while materially improving margins and ultimately justify a much higher earnings multiple than IBM, then hold or add; otherwise, the current valuation looks stretched because IRM trades at 249.6x P/E versus IBM’s 26.5x despite a 2.2% net margin and only a 4/9 Piotroski score.
IRM trades at a large valuation premium to IBM on both earnings and sales-based multiples, yet the implied price from IBM P/E framework is far below the current stock price. The market is therefore assigning IRM a much richer multiple despite a weaker profitability profile.
Supporting Metrics